InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc. /DE/

DNTH Clue Score31
United States Fiscal year ends December CIK 0001690585
$82.37 -0.07% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $82.37 +600.43% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Sep 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−9.3Net income−9.4Fiscal year 2017Revenue0.0Operating income−35.7Net income−35.5Fiscal year 2018Revenue0.0Operating income−60.0Net income−57.5Fiscal year 2019Revenue0.0Operating income−83.0Net income−76.8Fiscal year 2020Operating income−78.7Net income−74.9EPS, diluted−1.71Fiscal year 2021Operating income−74.7Net income−71.1EPS, diluted−1.29Fiscal year 2022Operating income−29.7Net income−28.5EPS, diluted−32.57Fiscal year 2023Revenue2.8Operating income−48.2Net income−43.6EPS, diluted−8.45Fiscal year 2024Revenue6.2 +120.6%Operating income−101.9Net income−85.0EPS, diluted−2.55Fiscal year 2025Revenue2.0 −67.3%Operating income−177.9Net income−162.3EPS, diluted−4.20
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.0 0.0 n/a n/a n/a 2.8 6.2 2.0
Growth +120.6% −67.3%
Operating income −9.3 −35.7 −60.0 −83.0 −78.7 −74.7 −29.7 −48.2 −101.9 −177.9
Net income −9.4 −35.5 −57.5 −76.8 −74.9 −71.1 −28.5 −43.6 −85.0 −162.3
Growth
EPS, diluted n/a n/a n/a n/a −1.71 −1.29 −32.57 −8.45 −2.55 −4.20

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−1,704.7%Net margin−1,541.2%Fiscal year 2024Operating margin−1,633.7%Net margin−1,362.8%Fiscal year 2025Operating margin−8,739.3%Net margin−7,973.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a n/a n/a −1,704.7% −1,633.7% −8,739.3%
Net margin n/a n/a n/a n/a n/a n/a n/a −1,541.2% −1,362.8% −7,973.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−6.5Capital expenditure−0.1Free cash flow−6.7Fiscal year 2017Operating cash flow−22.3Capital expenditure−2.2Free cash flow−24.5Fiscal year 2018Operating cash flow−41.9Capital expenditure−7.7Free cash flow−49.6Fiscal year 2019Operating cash flow−57.1Capital expenditure−3.1Free cash flow−60.2Fiscal year 2020Operating cash flow−64.0Capital expenditure−0.4Free cash flow−64.4Fiscal year 2021Operating cash flow−59.5Capital expenditure−1.3Free cash flow−60.8Fiscal year 2022Operating cash flow−29.1Capital expenditure−0.3Free cash flow−29.4Fiscal year 2023Operating cash flow−36.9Fiscal year 2024Operating cash flow−78.2Fiscal year 2025Operating cash flow−129.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.5 −22.3 −41.9 −57.1 −64.0 −59.5 −29.1 −36.9 −78.2 −129.1
Capital expenditure −0.1 −2.2 −7.7 −3.1 −0.4 −1.3 −0.3 n/a n/a n/a
Free cash flow −6.7 −24.5 −49.6 −60.2 −64.4 −60.8 −29.4 n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash4.5Shareholders’ equity−8.9Fiscal year 2017Cash51.4Shareholders’ equity−42.1Fiscal year 2018Cash58.3Shareholders’ equity145.6Fiscal year 2019Cash65.1Shareholders’ equity141.2Fiscal year 2020Cash58.2Shareholders’ equity143.9Fiscal year 2021Cash131.7Shareholders’ equity−17.2Fiscal year 2022Cash15.4Shareholders’ equity−44.4Fiscal year 2023Cash132.3Shareholders’ equity168.9Fiscal year 2024Cash22.8Shareholders’ equity352.5Fiscal year 2025Cash51.1Shareholders’ equity493.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.5 51.4 58.3 65.1 58.2 131.7 15.4 132.3 22.8 51.1
Shareholders’ equity −8.9 −42.1 145.6 141.2 143.9 −17.2 −44.4 168.9 352.5 493.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.0 0.0 0.0 0.0 n/a n/a n/a 2.8 6.2 2.0
Growth +120.6% −67.3%
5.8 27.9 41.3 59.2 50.6 46.8 29.4 32.8 83.1 145.6
3.5 7.8 18.6 23.8 28.1 27.9 6.7 18.2 25.0 34.3
−9.3 −35.7 −60.0 −83.0 −78.7 −74.7 −29.7 −48.2 −101.9 −177.9
Growth
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−9.4 −35.5 −57.5 −76.8 −74.9 −71.1 −28.5 −43.6 −85.0 −162.3
Growth
Per share
n/a n/a n/a n/a −1.71 −1.29 −32.57 −8.45 −2.55 −4.20
n/a n/a n/a n/a −1.71 −1.29 −32.57 −8.45 −2.55 −4.20
Growth
n/a n/a n/a n/a 43.9 54.9 0.9 5.2 33.3 38.6
n/a n/a n/a n/a 43.9 54.9 0.9 5.2 33.3 38.6
Growth +25.1% −98.4% +489.5% +546.4% +15.9%

† The diluted share count jumps at 2022 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.